| Company Name: |
Suzhou Meishi Biotechnology Co., Ltd.
|
| Tel: |
1173954148q |
| Email: |
meishipharma@126.com |
| Products Intro: |
Product Name:262376-75-0
CAS:262376-75-0
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HMR-1426
CAS:262376-75-0
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
3aH-Indeno[1,2-d]thiazol-3a-ol, 6-chloro-8,8a-dihydro-2-phenyl- manufacturers
- HMR-1426
-
- $1520.00 / 25mg
-
2025-08-21
- CAS:262376-75-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 3aH-Indeno[1,2-d]thiazol-3a-ol, 6-chloro-8,8a-dihydro-2-phenyl- Basic information |
| | 3aH-Indeno[1,2-d]thiazol-3a-ol, 6-chloro-8,8a-dihydro-2-phenyl- Chemical Properties |
| Boiling point | 483.2±55.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | pka | 11.36±0.40(Predicted) |
| | 3aH-Indeno[1,2-d]thiazol-3a-ol, 6-chloro-8,8a-dihydro-2-phenyl- Usage And Synthesis |
| Uses | HMR1426 is an orally active, potent gastric emptying inhibitor. HMR1426 reduces food intake and the rate of gastric emptying, decreases body weight and fat mass and shows an anorectic potential in rats. HMR1426 has the potential for obesity research[1]. | | References | [1] Sylvia Ortmann, et al. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. Obes Res. 2004 Aug;12(8):1290-7. DOI:10.1038/oby.2004.163 |
| | 3aH-Indeno[1,2-d]thiazol-3a-ol, 6-chloro-8,8a-dihydro-2-phenyl- Preparation Products And Raw materials |
|